Harbin Gloria Pharmaceuticals

Harbin Gloria Pharmaceuticals Co., Ltd. and its subsidiaries research, develop, produce, and sell pharmaceutical products in the People's Republic of China and internationally. Its portfolio includes cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamin supplements, electrolyte drugs, hypoglycemic drugs, analgesics, digestive system and metabolic drugs, anti-infective drugs, and anti-tumor drugs. The company also offers injectable products such as deer antler polypeptide injections, Annao pills and tablets, potassium chloride sustained-release tablets, sodium creatine phosphate for injection, ginkgo biloba extract injections, vitamin B12, fluorouracil for injection, and bleomycin hydrochloride for injection, as well as pravastatin sodium tablets, olmesartan medoxomil amlodipine tablets, and edoxaban tosylate tablets. In addition, it engages in pharmaceutical promotion, project investment, investment services, trade import and export, wholesale and retail, and technology promotion and application services. Founded in 2000, the company is headquartered in Harbin, the People's Republic of China.